Literature DB >> 15748838

Courting a cure for fragile X.

Gül Dölen1, Mark F Bear.   

Abstract

Fragile X syndrome is the most common heritable cause of mental retardation. Previous work has suggested that overactive signaling by group I metabotropic glutamate receptors (mGluRs) may be a mechanism underlying many of the disease symptoms. As a test of this theory, McBride et al. show that in a Drosophila model for Fragile X syndrome, treatment with mGluR antagonists can rescue short-term memory, courtship, and mushroom body defects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748838     DOI: 10.1016/j.neuron.2005.02.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  8 in total

1.  Pharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatment.

Authors:  Catherine H Choi; Brian P Schoenfeld; Aaron J Bell; Paul Hinchey; Maria Kollaros; Michael J Gertner; Newton H Woo; Michael R Tranfaglia; Mark F Bear; R Suzanne Zukin; Thomas V McDonald; Thomas A Jongens; Sean M J McBride
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

2.  Substitution of critical isoleucines in the KH domains of Drosophila fragile X protein results in partial loss-of-function phenotypes.

Authors:  Paromita Banerjee; Shweta Nayar; Sarita Hebbar; Catherine F Fox; Michele C Jacobs; Jae H Park; Joyce J Fernandes; Thomas C Dockendorff
Journal:  Genetics       Date:  2006-12-28       Impact factor: 4.562

3.  Open-label memantine in fragile X syndrome.

Authors:  Craig A Erickson; Jennifer E Mullett; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-07-16

4.  Cholinergic dysfunction in fragile X syndrome and potential intervention: a preliminary 1H MRS study.

Authors:  Shelli R Kesler; Amy A Lightbody; Allan L Reiss
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

Review 5.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

6.  Using Drosophila as a tool to identify Pharmacological Therapies for Fragile X Syndrome.

Authors:  Sean M McBride; Sandra L Holloway; Thomas A Jongens
Journal:  Drug Discov Today Technol       Date:  2012-09-24

7.  Interaction between Ephrins and mGlu5 metabotropic glutamate receptors in the induction of long-term synaptic depression in the hippocampus.

Authors:  Sonia Piccinin; Carlo Cinque; Laura Calò; Gemma Molinaro; Giuseppe Battaglia; Laura Maggi; Ferdinando Nicoletti; Daniela Melchiorri; Fabrizio Eusebi; Peter V Massey; Zafar I Bashir
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

8.  2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice.

Authors:  Réno M Gandhi; Cary S Kogan; Claude Messier
Journal:  Front Cell Neurosci       Date:  2014-03-06       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.